|
|
| home about us advertise with us downloads links privacy contact us site map copyright policy |
| ||
c0000441811 Bethlehem Pike 2303 North * Bldg. Broad C, Suite In fact, many of my patients with diarrhea predominant irritable bowel syndrome who have not responded to prior standard therapy for irritable bowel syndrome have noted significant clinical improvement while taking Alosetron. Recently I attended the American College of Gastroenterology meetings in New York City where a symposium was held by the world's experts regarding irritable bowel syndrome. In summary, I have found Alosetron to be a valuable medication and I would hope the Food & Drug Administration would continue to allow the use of Alosetron for the treatment of diarrhea predominant irritable bowel syndrome.Patient Publist 9-05Use and effectiveness of chlorophyllin in controlling odor for those with bowel or bladder control problems. Often not recognized by physicians, pelvic floor disorders can cause pain and disrupt bowel and bladder control. How perception of physical sensations may contribute to functional bowel disorder symptoms. Personal account and practical tips on living with the challenges of bowel dysfunction. This brochure reviews therapies for colon and rectal cancer that may affect bowel continence. This brochure reviews the use of episiotomy and common symptoms related to bowel function after delivery. Use and effectiveness of Chlorophyllin in controlling odor for those with bowel or bladder control problems. Often not recognized by physicians, pelvic floor disorders can cause pain and disrupt bowel and bladder control. By: Jacob C. Langer, MD 817-CVS. Cyclic Vomiting Syndrome. beatingbowelcancerbookletOur mission is to raise awareness of the symptoms of bowel cancer, promote early diagnosis and encourage open access to treatment choice. We have a committed team of both staff and volunteers who are dedicated to helping in the fight against bowel cancer. Yet we need to encourage people not to be embarrassed about discussing bowel cancer and all that goes with it. When we eat, the nutrients are taken out of our food before it gets to the bowel. Bowel cancer is cancer in any part of the colon or rectum that forms most of the large intestine or bowel. Untreated it will increase in size protruding into the lumen of the bowel and may cause blockage or can ulcerate leading to blood loss and anaemia. At the time of writing, there is no national screening programme for bowel cancer in place. For example, if bowel cancer runs in your family you should talk to your GP about being screened. Beating Bowel Cancer is a national charity working to raise awarenesspi-IBS-nov.inddIrritable bowel syndrome (IBS) is a disorder rather than a disease. Your gut is probably over-reacting to influences such as changes in diet or stressful events. It is very common, and most people experience IBS symptoms at some point in their lives. What are the symptoms of IBS? Having one of the following symptoms does not necessarily mean that you have IBS, but the more of them that you have, the more likely it is that you have IBS. Abdominal pain, usually in the lower abdomen (often relieved by having your bowels open) Faeces that are hard or lumpy or like rabbit pellets; or faeces that are loose or watery More frequent faeces `Morning rush' - having to defecate several times soon after you get up in the morning and after breakfast After passing faeces, a feeling that you have not emptied your bowel completely A feeling that your abdomen is bloated or distended Passing a lot of wind What is the cause of IBS? Occasionally, IBS may start after a bowel infectionDevinThis information may be freely copied and distributed only if unaltered, with complete original content including: © Devin Starlanyl, 2003. IBS can be disruptive, affecting ability to travel, employment, social contact and other normal functioning. Recent research indicates that the same mechanism behind the central sensitization of fibromyalgia syndrome (FMS) may also be involved in IBS. (1) Approximately 20% of patients with IBS, and the IBS symp-toms, can be worsened by coexistent FMS (2) and some myofascial trigger points (TrPs). Fewer than three bowel movements a week. Normally, people do not feel pain sensations from the bowel, only pressure sensa-tions such as distension from gas. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Fibromyalgia in patients with irritable bowel syndrome. Irritable bowel syndrome as a common precipitant of central sensitization.British Medical JournalParrots may talk, but are not likely to discuss their bowels. However, the ®rst credible English language descriptions of irritable bowel syndrome (IBS) appeared in the early 19th century. In 1849, Cumming asks incredu-lously: ªthe bowels are at one time constipated and at another lax in the same personhow the disease has two Figure 1 Results of a Medline literature search for irritable bowel syndrome (IBS) and irritable colon syndrome (ICS) by decade, for the 30 years ending with 1997. From this experience, the authors were able to report many of the features that we recognize as those of the IBS (or the irrita-ble colon syndrome as they termed it). The ®rst attempt to classify all the functional gastro-intestinal disorders appears in the index of my book The Irritable Gut, published in 1979. 9 In 1978, led by Ken Hea-ton, Adrian Manning and I reported results obtained by questionnaire administered to Bristol outpatients with abdominal pain and disordered bowelch001-toc_4409ch00_toc_4430 5/19/05 9:57 AM Page i Journal of Cognitive Psychotherapy The Official Quarterly of the and Irritable Bowel Syndrome Cognitive Psychotherapy and Irritable Bowel Syndrome: Cognitive-Behavioral Therapies for Irritable Bowel Syndrome 101 Irritable Bowel Syndrome 125 Predictors of Pain Affect in Patients With Irritable Bowel Syndrome 151 Towards a Better Understanding of Anxiety in Irritable Bowel Syndrome:Checklist - IBSA number of different over-the-counter products are now available to treat the symptoms of irritable bowel syndrome. This card discusses which treatments to recommend for symptomatic control of the condition. It also emphasises the importance of interviewing the patient when counter-prescribing Irritable bowel syndrome (IBS) is a disorder of the gut characterised by: Intermittent and colicky abdominal pain Abdominal distension, which is often worse in the morning, and is quantifiable by computer tomographic studies but is of unknown aetiology A range of other non-specific signs and symptoms, eg, a feeling of incomplete evacuation on defaecation and passage of rectal mucus Some patients report urgency of defaecation and painless diarrhoea while others complain of constipation. In some patients, episodes of diarrhoea alternating with constipation are experienced. Given the many presentations of the disease as indicated by the term "syndrome", there is no singletegaserod (Zelnorm)Tegaserod was compared to placebo in patients with irritable bowel syndrome (IBS) in several trials. In a preliminary study in healthy men, tegaserod significantly accelerated gastric emptying (p<0.01), small bowel transit (p<0.05), and colonic transit (p=0.01 for tablets and p=0.05 for intravenous [IV] administration). In three larger trials involving patients with constipation-predominant IBS, tegaserod decreased abdominal pain (p<0.05), increased patient's perception of relief from symptoms (p<0.03), increased the number of bowel movements patients had per week (p<0.05), and softened stool (p<0.05). In a study evaluating tegaserod in patients with diarrhea-predominant IBS, tegaserod did not significantly solidify stool or decrease bowel movement frequency. This difference was statistically significant for complete spontaneous bowel movements (CSBM) changes averaged over the first four weeks of treatment and the full 12 weeks of treatment. TegaserodGR 53The problem is that the symptoms of Irritable Bowel Syndrome are quite non-specific. The abdominal pain, bloating and bowel disturbances are the kind of symptoms the bowel would produced when it is irritated, irrespective of whether the irrita-tion is caused by inflammation, infection, toxins, radiation or nerves. And any irritation anywhere in the body is made worse if the patient is tense or upset. So the symptoms just mean that something is not right with the bowel. It's an unfor-tunate fact of life that if there is something that you are particularly fearful of, then the fear itself tends to make that thing more likely - like mak-ing your bowels loose when something out of the ordinary happens. Among medical measures, you have found Colofac helps to quieten your bowels down. Other possibilities to suppress an active bowel would include Imodium and a medication called Questran, which I find particularly helpful for people with IBS who have diarrhoea. Questran binds bileSheppard NOCAins 8038 19aug- Because early symptoms of ovarian cancer can be non-specific it is usually detected in its later stages. - This year 1,500 Canadian women will die of ovarian cancer. It is the fifth ranking cause of cancer death for women. They can mimic menopausal or peri-menopausal symptoms; irritable bowel syndrome/non ulcer dyspepsia; or depression or stress. If these symptoms persist for 2-3 weeks or longer, consider ovarian cancer in your diagnosis. Diagnostic Tests These tests can assure both your patient and you that a potentially lethal diagnosis is unlikely: - If symptoms persist and tests are negative, consider referral to a gynecologist or gynecologic oncologist. Ils peuvent ressembler aux symptômes de la ménopause ou de la périménopause, au syndrome du colon irritable ou de la dyspepsie sans ulcère, ou aux symptômes de la dépression ou du stress.doi:10.1053/j.gastro.2004.04.028See article on page 1657. 4-6 Most of the total 5-HT content in the body is localized in gastrointestinal EC cells. EC cells release 5-HT in a regulated and calcium-dependent manner and they express mechano- and che-mosensitive ion channels, a variety of ligand-gated ion channels, and G-protein- coupled receptors on the EC cell surface.4,5 Activation of calcium-permeable ion chan-nels or some G-protein-linked receptors leads to a rise in intracellular calcium and 5-HT secretion. 4,5 Regulated secretion of 5-HT by EC cells can be enhanced or inhib-ited by the action of signaling molecules released from surrounding cells and by nerve terminals supplying the mucosa.4,5 Modulation of 5-HT release from EC cells is critical to normal and perhaps abnormal gastrointestinal function. Based on the summary provided above, it is not sur-prising that disorders of 5-HT signaling have been im-plicated in the pathogenesis of some disorders of gastro-intestinal motility, particularlymanage_treatThe new Rome II Criteria are simpler than Rome I (see Fig 1), and have undoubtedly improved the comparability of clinical trail populations though care is needed to avoid these criteria acting as blinkers and inhibiting progress in understanding pathogenesis. Epidemiological studies suggest that symptom clusters define three sub-types of IBS. 1: characterised by loose stools passed with urgency with minimal straining, one characterised by hard stools and straining and incomplete evacuation but also some urgency and notably a similar bowel frequency. Finally there is a group of patients with minimal disturbance of stooling and a normal stool frequency whose main complaint is pain and bloating 1. It is apparent therefore that stool frequency is an unreliable guide to sub typing since it depends on social and psychological factors. It is probably more useful to define IBS subtypes based on the stool consistency, which is closely related to colonic transit 2 Sub-typing IBSNL 139What is diarrhea? Diarrhea is defined as the frequent passage of watery, loose stools, accompanied by an excessive loss of fluid and electrolytes. Another standard definition of diarrhea is passing more than three liquid bowel movements daily, or more than one litre of stool from an ileostomy or colostomy per day. The causes of osmotic diarrhea may be lactose intolerance, fat malabsorption, dumping syndrome after gastric surgery, or certain medications (i.e. hypertonic or sorbitol-containing liquid medications). Causes of this type of diarrhea are irritable bowel syndrome, surgical bypass, gastric and intestinal resections, antibiotics, or stress. Some people who are malnourished or on bowel rest, may experience diarrhea for the first few days when starting to eat again because the bowel wall's ability to function decreases when it is not used and resumes normal function slowly. Because of its cathartic effect, especially as aloe latex or juice, caution should be used inibsqinfo1-15-04The IBS-QOL is a self-report quality-of-life measure specific to Irritable Bowel Syndrome (IBS) that can be used to assess the impact of IBS and its treatment. 1. I feel helpless because of my bowel problems. 2. I am embarrassed by the smell caused by my bowel problems 3. 4. I feel vulnerable to other illnesses because of my bowel problems. 5. I feel fat because of my bowel problems. 6. I feel like I'm losing control of my life because of my bowel problems. 7. I feel my life is less enjoyable because of my bowel problems. 14. I feel like I irritate others because of my bowel problems 15. 16. I feel irritable because of my bowel problems 17.CAG_IP_IBS_walkerton_cleanFINALcsReleased February 27, 2004 at the Canadian Digestive Diseases Week (CDDW), it is the largest study of its kind. The study is part of the much larger Walkerton Health Study, which is following the residents of Walkerton, Ont. Several people died. Many Walkerton residents have continued to suffer abdominal pain and changes in bowel habit, a condition call post-infectious IBS. "It's a common phenomenon all clinicians will recognize," researcher Dr. John Marshall said. "One of the frustrating things with IBS is people can describe the symptoms, but clinicians struggle to find the source and explanation for these symptoms, so patients feel they're dismissed," said Dr. John Marshall (Assistant Professor of Medicine, McMaster University). "It can be a nuisance or quite disabling, and many people in Walkerton remain unwell." Increased IP means the bowel lining allows more particles and chemicals to pass through, which could irritate its deeper tissue layers. We need to learnDiarrhea in Infants and Children- Rotavirus » Most common cause of diarrheal illness in pediatric patients » Increased incidence during winter months » Lasts 2 to 8 days » Children usually have antibodies by age 2, decreasing later incidence and severity Causes - Often unrecognized because requires special media for culture - Noted most often in patents with altered intestinal flora after use of antibiotics - Most common viral pathogens occur during winter - Usually do not help in determining cause of diarrhea - Stool cultures for bacterial pathogens Remember campylobacter requires specific media - Abdominal x-rays may be helpful in some cases - Proper handling and cooking of meat, poultry and fish - Can either decrease or increase transit time in boweldoi:10.1016/j.neuroimage.2004.01.037Received 3 November 2003; revised 15 January 2004; accepted 15 January 2004 The neurocognitive pathways by which placebo effects operate are poorly understood. Positron emission tomography (PET) imaging was used to assess the brain response of patients with chronic abdominal pain (irritable bowel syndrome; IBS) to induced intestinal discomfort both before and after a 3-week placebo regimen. This is the first study to identify a neural pathway from a region of the brain associated with placebos and affective thought to a region closely linked to the placebo-related outcome of diminished pain unpleasantness. Overview of the study Patients with irritable bowel syndrome (IBS) were scanned using PET both before and following 3 weeks of taking a placebo (or active drug) for their gastrointestinal symptoms. IBS is a common syndrome characterized by chronic, recurrent abdominal pain and discomfort (associated with altered bowel habits). Altered rectal perception is aIBS_IM_Comm_ToolImplementation & Communication Tool This document is designed to be used as a checklist to assist with communicating the IBS guideline content to target groups and to plan local implementation and measurement. The guideline includes evidence-based content formatted for health care professionals and patients. You may wish to reformat some of the content for various target groups and various implementation "vehicles." There is good evidence that using a combination of implementation strategies is more effective than using single strategies. For education and detailing you will want to use the all the Delfini IBS Guideline Resource Kit contents along with the implementation strategies described below, including "IBS Case for Change In Irritable Bowel Syndrome, currently in our health care systems, there are gaps in - 1. IBS is a chronic medical condition characterized by episodic abdominal discomfort associated with altered bowel habits I was irritableduring the end of the1 | 2 | 3
| 4 | 5 | 6
| 7 | 8 | 9
| 10 | 11 | 12
| 14 | 15 | | ||
